Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9559 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9559 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9489 |
High Similarity |
NPD1549 |
Phase 2 |
0.9362 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9247 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9184 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.911 |
High Similarity |
NPD7411 |
Suspended |
0.9091 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9065 |
High Similarity |
NPD2796 |
Approved |
0.906 |
High Similarity |
NPD7075 |
Discontinued |
0.9041 |
High Similarity |
NPD4380 |
Phase 2 |
0.8993 |
High Similarity |
NPD1510 |
Phase 2 |
0.8986 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8978 |
High Similarity |
NPD1240 |
Approved |
0.8919 |
High Similarity |
NPD1934 |
Approved |
0.8859 |
High Similarity |
NPD7819 |
Suspended |
0.8849 |
High Similarity |
NPD1607 |
Approved |
0.8792 |
High Similarity |
NPD6801 |
Discontinued |
0.8758 |
High Similarity |
NPD6959 |
Discontinued |
0.8684 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.863 |
High Similarity |
NPD6799 |
Approved |
0.8611 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.859 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8544 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8503 |
High Similarity |
NPD1511 |
Approved |
0.8497 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8487 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8483 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8471 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8471 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8471 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8451 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8429 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8411 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8389 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8377 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8333 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8299 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8288 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8261 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8258 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8231 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8212 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8205 |
Intermediate Similarity |
NPD3749 |
Approved |
0.82 |
Intermediate Similarity |
NPD2532 |
Approved |
0.82 |
Intermediate Similarity |
NPD2534 |
Approved |
0.82 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8199 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8194 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8175 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8169 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8151 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8137 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8098 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8092 |
Intermediate Similarity |
NPD920 |
Approved |
0.8086 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8082 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8079 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8067 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8028 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8027 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8027 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7975 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7973 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7963 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7961 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7959 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7943 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7933 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7933 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7917 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7902 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7892 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7885 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7883 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7877 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7877 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7849 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7849 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7848 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7815 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7793 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7763 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7756 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7748 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7733 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7702 |
Intermediate Similarity |
NPD919 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7687 |
Intermediate Similarity |
NPD943 |
Approved |
0.7669 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7669 |
Intermediate Similarity |
NPD5710 |
Approved |
0.766 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7657 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7613 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7605 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7603 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.76 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7562 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7515 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3225 |
Approved |
0.75 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7466 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7448 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7448 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7438 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7432 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7431 |
Intermediate Similarity |
NPD4749 |
Approved |
0.743 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7415 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7405 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7377 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7361 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7357 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7347 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7338 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7326 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7325 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7325 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7315 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7301 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7292 |
Intermediate Similarity |
NPD1201 |
Approved |
0.729 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7284 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7267 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7246 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7239 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7216 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7215 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7211 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7208 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7203 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD3764 |
Approved |
0.72 |
Intermediate Similarity |
NPD411 |
Approved |
0.7197 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7195 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD37 |
Approved |
0.7171 |
Intermediate Similarity |
NPD447 |
Suspended |
0.717 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7169 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7161 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7161
|
Intermediate Similarity |
NPD1471 |
Phase 3 |